Powered by

Arkuda Therapeutics to Participate in Stifel's 3rd Annual CNS Day

Mar 25, 2021 - PR Newswire
Event Announcements

PR Newswire

 Arkuda Therapeutics, a biotechnology company applying new insights into lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease, today announced that Gerhard Koenig, PhD, Co-Founder, President and CEO of Arkuda Therapeutics, will present at Stifel's 3rd Annual CNS Day on Thursday, April 1, 2021 at 1:00 p.m. ET.

Presentation Details

Date: Thursday, April 1, 2021Time: 1:00 p.m. ETURL to Access Webcast:https://wsw.com/webca...